Home > Boards > US OTC > Miscellaneous > Cardax Inc. (CDXI)

Also Bristol-Myers Squibb???

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sweet crude Member Profile
 
Followed By 182
Posts 18,086
Boards Moderated 4
Alias Born 11/07/05
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 8:02:44 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/28/2019 8:04:06 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 2/8/2019 6:02:33 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 2/7/2019 5:05:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2019 8:01:49 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/4/2019 5:03:38 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 12/14/2018 5:07:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2018 8:01:50 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2018 5:04:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2018 8:01:26 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2018 5:04:34 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 7/30/2018 8:03:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2018 8:01:22 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 7/25/2018 6:05:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2018 5:01:44 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/25/2018 6:01:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 1:46:59 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 6/22/2018 1:03:58 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 6/21/2018 9:19:35 AM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 6/21/2018 9:05:42 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 6/20/2018 9:19:15 AM
Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) Edgar (US Regulatory) - 6/20/2018 9:06:16 AM
sweet crude   Wednesday, 10/08/14 01:04:28 PM
Re: None
Post # of 42 
Also Bristol-Myers Squibb???

Tamar D. Howson , age 65, will serve as a director of the Company commencing June 16, 2014. She has served as an independent corporate business development and strategy consultant to life science companies since 2011. From 2009 to 2011, she provided business development support to life sciences companies as a member of the transaction team at JSB-Partners. From 2007 to 2008, Ms. Howson served as Executive Vice President, Corporate Business Development at Lexicon Pharmaceuticals. From 2001 to 2007, Ms. Howson served as Senior Vice President, Corporate and Business Development at Bristol-Myers Squibb.

Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!

Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist